| Literature DB >> 33911966 |
Mervat Morsy Abbas Ahmed El-Gendy1, Mohamed F Awad2,3, Fareed Shawky El-Shenawy3, Ahmed Mohamed Ahmed El-Bondkly4.
Abstract
L-Asparaginase is an antileukemic agent that depletes L-asparagine "an important nutrient for cancer cells" through the hydrolysis of L-asparagine into L-aspartic acid and ammonia leading to leukemia cell starvation and apoptosis in susceptible leukemic cell populations. Moreover currently, bacterial L-asparaginase has been limited by problems of lower productivity, stability, selectivity and a number of toxicities along with the resistance towards bacterial L-asparaginase. Then the current work aimed to provide pure L-asparaginase with in-vitro efficacy against various human carcinomas without adverse effects related to current L-asparaginase formulations. Submerged fermentation (SMF) bioprocess was applied and improved to maximize L-asparaginase production from Fusarium equiseti AHMF4 as alternative sources of bacteria. The enzyme production in SMF was maximized to reach 40.78 U mL-1 at the 7th day of fermentation with initial pH 7.0, incubation temperature 30 °C, 1.0% glucose as carbon source, 0.2% asparagine as nitrogen source, 0.1% alanine as amino acid supplement and 0.1% KH2PO4. The purification of AHMF4 L-asparaginase yielded 2.67-fold purification and 48% recovery with final specific activity of 488.1 U mg-1 of protein. Purified L-asparaginase was characterized as serine protease enzyme with molecular weight of 45.7 kDa beside stability at neutral pH and between 20 and 40 °C. Interestingly, purified L-asparaginase showed promising DPPH radical scavenging activity (IC50 69.12 μg mL-1) and anti-proliferative activity against cervical epitheloid carcinoma (Hela), epidermoid larynx carcinoma (Hep-2), hepatocellular carcinoma (HepG-2), Colorectal carcinoma (HCT-116), and breast adenocarcinoma (MCF-7) with IC50 equal to 2.0, 5.0, 12.40, 8.26 and 22.8 μg mL-1, respectively. The enzyme showed higher activity, selectivity and anti-proliferative activity against cancerous cells along with tiny cytotoxicity toward normal cells (WI-38) which indicates that it has selective toxicity and it could be applied as a less toxic alternative to the current formulations.Entities:
Keywords: Anti-proliferative; Antioxidant; Characterization; Fusarium sp.; L-Asparaginase; Optimization; Purification
Year: 2021 PMID: 33911966 PMCID: PMC8071902 DOI: 10.1016/j.sjbs.2021.01.058
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
Fig. 1Qualitative production of L-asparaginase enzyme (a), cultural (b) and microscopic characteristics of AHMF4 isolate (c) on modified Czapex’s Dox agar medium.
Chemotypic and phenotypic characteristics of AHMF4 isolate.
| Chemotypic characteristics/growth period (day) | Macro/microscopic characteristics | ||||
|---|---|---|---|---|---|
| Fatty acid composition (%, w/w) | 4 | 7 | 10 | 14 | |
| 14:0 | - | - | 0.32 ± 0.01 | 0.47 ± 0.02 | Colonies growing with diameter 5.1 cm on PDA after five days, aerial mycelium appeared white turned to brownish white, reverse pale, sporodochia present, branched conidiophores scattered in the aerial mycelium. Macroconidia are formed from conidiophores, three-septate, 29–46 × 3–5 µm, cylindrical, curved, with foot cell. Microconidia are abundant, ellipsoidal, one celled, curved, and formed from long lateral phialides, 9 × 3.0 µm. Chlamydo spores were hyaline, globose, rough-walled, borne in pairs on short lateral hyphal branched or intercalary, 5–8 µm. |
| 15:0 | 0.20 ± 0.13 | 0.92 ± 0.14 | 1.16 ± 0. 12 | 0.88 ± 0.14 | |
| 16:0 | 5.51 ± 0.21 | 6.11± 0.30 | 8.00 ± 0.40 | 2.41 ± 0.45 | |
| 16:1 | - | 1.51± 0.02 | 2.19 ± 0.02 | 1.21 ± 0.01 | |
| 16:2 | 0.11 ± 0.0 | 0.30 ± 0.00 | 0.71 ± 0.01 | - | |
| 17:0 | 0.80 ± 0.01 | 1.93 ± 0.01 | 2.06 ± 0.02 | - | |
| 17:2 | 0.16 ± 0.01 | 1.59 ± 0.05 | 1.90 ± 0.06 | 1.00 ± 0.04 | |
| 18:0 | 8.10 ± 0.1 | 10.60 ± 0.18 | 14.00 ± 0.22 | 10.42 ± 0.40 | |
| 18:1 | 10.00 ±1.05 | 19.53 ±1.08 | 22.86 ± 1.10 | 18.71 ± 1.06 | |
| 18:2 | 16.77 ± 0.30 | 22.04 ± 0.8 | 28.15 ± 1.18 | 18.06 ±1.09 | |
| 18:3 | 4.18 ± 0.12 | 5.15 ± 0.18 | 6.01 ± 0.25 | 4.91± 0.21 | |
| 20:4 | - | - | 0.52 ± 0.01 | 0.50 ± 0.01 | |
| 22:5 | 0.19 ± 0.1 | 0.74 ± 0.09 | 0.77 ± 0.13 | 0.33 ± 0.11 | |
| 22:6 | - | 1.12 ± 0.2 | 1.00 ± 0.1 | - | |
| 24:0 | 0.25 ± 0.01 | 0.29 ± 0.01 | 1.00 ± 0.02 | - | |
| 26:0 | - | 0.50 ± 0.00 | 0.10 ± 0.00 | - | |
| 18:1 ω9c | - | 1.31 ± 0.02 | 1.40 ± 0.03 | 1.00 ± 0.02 | |
| 18:2 ω6c | 3.51 ± 0.00 | 7.75 ± 0.01 | 7.75 ± 0.02 | 6.44 ± 0.01 | |
Fig. 2Phylogenetic tree of 18S rDNA sequences performed by the neighbor joining system for fungal strain AHMF4 and similar fungi.
Optimization of L-asparaginase production process parameters under submerged fermentation by Fusarium equiseti AHMF4.
| Process parameter | L-Asparaginase activity (U mL−1) |
|---|---|
| 1 | 2.26 |
| 4 | 8.73 |
| 7 | 12.57 |
| 10 | 8.77 |
| 13 | 6.68 |
| 20 | 8.57 |
| 27 | 12.11 |
| 30 | 18.95 |
| 37 | 7.52 |
| 5 | 8.15 |
| 6 | 14.05 |
| 7 | 19.25 |
| 8 | 13.38 |
| 9 | 8.44 |
| 10 | 6.78 |
| Starch | 7.89 |
| Lactose | 14.22 |
| Sorbitol | 14.22 |
| Fructose | 15.74 |
| Sucrose | 19.76 |
| Glucose | 22.54 |
| Without carbon source | 0.31 |
| Asparagine (control) | 31.01 |
| Malt extract | 12.08 |
| Beef extract | 13.33 |
| Peptone | 13.52 |
| Yeast extract | 14.07 |
| Sodium nitrate | 19.54 |
| Tryptone | 15.73 |
| Without nitrogen source | 1.00 |
| BaCl2 | 29.63 |
| NaCl | 31.56 |
| MgCl2 | 31.62 |
| KH2PO4 | 37.52 |
| CaCl2 | 19.95 |
| Glycine | 34.80 |
| Alanine | 40.78 |
| Methionine | 29.66 |
Purification stages of L-asparaginase yielded from Fusarium equiseti AHMF4 strain.
| Purification step | Total protein (mg) | Total activity (U) | Specific activity (U mg−1) | Yield (%) | Purification fold |
|---|---|---|---|---|---|
| Crude extract | 104 | 19,000 | 182.6 | 100 | 1.00 |
| (NH4)2SO4 precipitation (80%) | 53 | 14,300 | 269.8 | 75 | 1.47 |
| Anion exchange QFF | 32 | 12,100 | 378.1 | 63 | 2.07 |
| Gel filtration sephacryl-200 | 19 | 9275 | 488.1 | 48 | 2.67 |
Fig. 3SDS-PAGE analysis of L-asparaginase during the purification stages. lane 1, molecular weight marker; lane 2, crude enzyme; lane 3, (NH4)2SO4 precipitation; lane 4, ion exchange chromatography on anion QFF; lane 5, purified L-asparaginase on sephadex G-200.
Fig. 4Effect of temperature on the activity and stability of purified L-asparaginase from Fusarium equiseti AHMF4.
Fig. 5Effect of pH on the activity and stability of purified L-asparaginase from Fusarium equiseti AHMF4.
Effect of metal ions and enzyme inhibitors on purified L-asparaginase activity.
| Metal ion and enzyme inhibitor | Concentration (mM) | L-Asparaginase relative activity (%)* |
|---|---|---|
| Control | – | 100.0 |
| K+ | 50 | 105.8 |
| Na+ | 50 | 99.1 |
| Mg2+ | 50 | 143.3 |
| Ca2+ | 50 | 77.5 |
| Ba2+ | 10 | 122.5 |
| Cu2+ | 10 | 100.0 |
| Mn2+ | 10 | 100.0 |
| Fe3+ | 10 | 100.0 |
| Aspartic proteases inhibitor | ||
| Pepstatin A | 5 | 121.9 |
| 10 | 107.1 | |
| 15 | 100.0 | |
| Serine proteases inhibitor | ||
| PMSF | 5 | 20.1 |
| 10 | 0.0 | |
| 15 | 0.0 | |
| Benzamidine | 5 | 12.15 |
| 10 | 0.0 | |
| 15 | 0.0 | |
| TLCK | 5 | 0.0 |
| 10 | 0.0 | |
| 15 | 0.0 | |
| Metallo proteases inhibitor | ||
| EDTA | 5 | 130.4 |
| 10 | 121.8 | |
| 50 | 102.4 | |
| EGTA | 5 | 123.7 |
| 10 | 119.0 | |
| 50 | 104.4 | |
| 1, 10-Phenanthroline | 5 | 116.5 |
| 10 | 107.9 | |
| 50 | 100.0 | |
| Cysteine protease inhibitor | ||
| bADA | 5 | 100.0 |
| 10 | 100.0 | |
| 15 | 100.0 | |
| E-64 | 5 | 100.0 |
| 10 | 100.0 | |
| 15 | 100.0 | |
| 2-Iodoacetamide | 5 | 100.0 |
| 10 | 100.0 | |
| 15 | 100.0 |
*The activity of L-asparaginase without any chemical additives defined as 100%.
Fig. 6Effect of purified L-asparaginase from Fusarium equiseti AHMF4 on colorectal carcinoma (HCT-116), liver carcinoma (HepG-2), breast carcinoma (MCF-7), cervical epitheloid carcinoma (HeLa) and epidermoid larynx carcinoma (Hep-2) compared with normal cells (WI-38).
Fig. 7DPPH scavenging activity of the purified L-asparaginase from Fusarium equiseti AHMF4 compared to ascorbic acid.